Contact us

877-469-1TRM
424-208-8866

Safety Study of Darinaparsin in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma

A Phase I Dose Excalation Study of Darinaparsin in Combination with CHOP in Previously Untreated Patients with Lymphomas who are Scheduled to Receive CHOP

For more information, please visit ClinicalTrials.gov

Patient Population Investigational Product(s) Phase Status
Lymphoma scheduled for CHOP (likely Peripheral T-Cell Lymphomas) Darinaparsin I Closed